Perspective Therapeutics (CATX) Net Equity Issued and Repurchased (2011 - 2023)
Perspective Therapeutics' (CATX) quarterly Net Equity Issued and Repurchased came in at $400000.0 in Q4 2023, down 99.16% quarter-over-quarter from $47.9 million in Q1 2021.
Powered by 
Analysis
Perspective Therapeutics (CATX) Net Equity Issued and Repurchased (2011 - 2023) Analysis & Trends
Perspective Therapeutics has disclosed Net Equity Issued and Repurchased across 7 years of filings, most recently posting $400000.0 for Q4 2023.
- In Q4 2023, Net Equity Issued and Repurchased changed N/A year-over-year to $400000.0; the TTM figure through Dec 2023 stood at $400000.0 (down 99.16% YoY), while the FY2024 annual figure was $275.8 million, up 75671.15% from the prior year.
- Net Equity Issued and Repurchased came in at $400000.0 for Q4 2023 at Perspective Therapeutics, down from $47.9 million in the prior quarter.
- In the past five years, Net Equity Issued and Repurchased ranged from a high of $47.9 million in Q1 2021 to a low of -$11000.0 in Q1 2019.
- Average Net Equity Issued and Repurchased over 3 years is $16.1 million, with a median of $400000.0 recorded in 2023.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Amgen | 211.73 Bn | 197.74 Bn | 7.24 Bn | - |
| 2 | Gilead Sciences | 180.92 Bn | 177.74 Bn | 6.22 Bn | 9.00 Mn |
| 3 | Vertex Pharmaceuticals | 132.16 Bn | 124.30 Bn | 2.84 Bn | - |
| 4 | Regeneron Pharmaceuticals | 82.89 Bn | 74.90 Bn | 3.93 Bn | 49.20 Mn |
| 5 | Argenx Se | 61.41 Bn | 56.23 Bn | 1.37 Bn | - |
| 6 | Moderna | 53.99 Bn | 48.85 Bn | 52.00 Mn | - |
| 7 | Alnylam Pharmaceuticals | 34.48 Bn | 31.18 Bn | 992.69 Mn | - |
| 8 | Biogen | 31.15 Bn | 29.86 Bn | 1.96 Bn | - |
| 9 | Roivant Sciences | 30.05 Bn | 30.05 Bn | 1.16 Mn | - |
| 10 | Perspective Therapeutics | 361.95 Mn | 361.95 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 400,000.00 |
| Mar 31, 2021 | 47.90 Mn |
| Mar 31, 2019 | -11,000.00 |
| Dec 31, 2018 | -113,000.00 |
| Sep 30, 2018 | 7.49 Mn |
| Jun 30, 2018 | 505,000.00 |
| Jun 30, 2014 | -4,185.00 |
| Sep 30, 2012 | 3.29 Mn |
| Mar 31, 2012 | -5,216.00 |
| Jun 30, 2011 | -118,149.00 |